Publication
Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE).
Journal Paper/Review - Apr 24, 2024
Meyer-Wilmes P, Huober Jens, Untch Michael, Blohmer J-U, Janni Wolfgang, Denkert Carsten, Klare Peter, Link Theresa, Rhiem Kerstin, Bayer C, Reinisch Mattea, Bjelic-Radisic Vesna, Zahm Dirk Michael, Hanusch Claus, Solbach Christine, Heinrich Georg, Hartkopf Andreas D, Schneeweiss Andreas, Fasching Peter Andreas, Filmann N, Nekljudova Valentina, Holtschmidt J, Stickeler Elmar, Loibl Sibylle
Meyer-Wilmes, P
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
297
12
Untch, Michael
88
0
Blohmer, J-U
7
0
Janni, Wolfgang
66
0
Denkert, Carsten
49
0
Klare, Peter
8
0
Link, Theresa
8
0
Rhiem, Kerstin
22
0
Bayer, C
Reinisch, Mattea
10
0
Bjelic-Radisic, Vesna
6
0
Zahm, Dirk Michael
2
0
Hanusch, Claus
42
0
Solbach, Christine
24
0
Heinrich, Georg
3
0
Hartkopf, Andreas D
13
0
Schneeweiss, Andreas
77
0
Fasching, Peter Andreas
1
0